Evidence map›Paper›PMID 27187475›Full record

ReviewToxins2016

The Regulatory Networks That Control Clostridium difficile Toxin Synthesis.

Isabelle Martin-Verstraete, Johann Peltier, Bruno Dupuy

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 158 citations in OpenAlex.

  1. Development of a high-throughput screening platform forAntimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. The emerging view on the roles of butyrate inInfection and immunity · 2025
    Review
  4. Article
  5. Proline Stickland fermentation supportsApplied and environmental microbiology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Genomic and phenotypic studies amongMicrobiology spectrum · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. The pH-responsive SmrR-SmrT system modulatesInfection and immunity · 2024
    Article
  16. Article
  17. Approaching pathogenicbioRxiv : the preprint server for biology · 2024
    Article
  18. Genomic and phenotypic characterization of aFrontiers in cellular and infection microbiology · 2024
    Article
  19. Microbiology spectrum · 2023
    Article
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Isabelle Martin-VerstraeteLaboratoire Pathogenèse des Bactéries Anaérobes, Department of Microbiology, Institut Pasteur, 25 rue du Dr Roux Paris, Paris 75015, France. isabelle.martin-verstreate@pasteur.fr.
Johann PeltierLaboratoire Pathogenèse des Bactéries Anaérobes, Department of Microbiology, Institut Pasteur, 25 rue du Dr Roux Paris, Paris 75015, France. johann.peltier@pasteur.fr.
Bruno DupuyLaboratoire Pathogenèse des Bactéries Anaérobes, Department of Microbiology, Institut Pasteur, 25 rue du Dr Roux Paris, Paris 75015, France. bdupuy@pasteur.fr.
Institut Pasteur · FR

Funding

Clostridium difficile Toxin Gene RegulationR01AI057637 · NIAID · TUFTS UNIVERSITY BOSTON · PI SONENSHEIN, ABRAHAM LINCOLN · 2005 to 2010
$1.4M
NIAID NIH HHS R01 AI057637
6 · The paper itself

Abstract

The pathogenic clostridia cause many human and animal diseases, which typically arise as a consequence of the production of potent exotoxins. Among the enterotoxic clostridia, Clostridium difficile is the main causative agent of nosocomial intestinal infections in adults with a compromised gut microbiota caused by antibiotic treatment. The symptoms of C. difficile infection are essentially caused by the production of two exotoxins: TcdA and TcdB. Moreover, for severe forms of disease, the spectrum of diseases caused by C. difficile has also been correlated to the levels of toxins that are produced during host infection. This observation strengthened the idea that the regulation of toxin synthesis is an important part of C. difficile pathogenesis. This review summarizes our current knowledge about the regulators and sigma factors that have been reported to control toxin gene expression in response to several environmental signals and stresses, including the availability of certain carbon sources and amino acids, or to signaling molecules, such as the autoinducing peptides of quorum sensing systems. The overlapping regulation of key metabolic pathways and toxin synthesis strongly suggests that toxin production is a complex response that is triggered by bacteria in response to particular states of nutrient availability during infection.

Indexed as

Bacterial ToxinsCatabolite RepressionClostridioides difficileCysteineProlineTranscription FactorsBacterial ToxinsCysteineProlineTranscription Factorscarbon catabolite repression systemC. difficilec-di-GMPgrowth phasePaLocquorum sensingsporulationstress signalstoxin regulation

Identifiers

PMID27187475
PMCPMC4885068
OpenAlexW2347869237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.